Myriad Genetics, Inc. Profile Avatar - Palmy Investing

Myriad Genetics, Inc.

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health …

Medical - Diagnostics & Research
US, Salt Lake City [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of MYGN's Analysis
CIK: 899923 CUSIP: 62855J104 ISIN: US62855J1043 LEI: - UEI: -
Secondary Listings
MYGN has no secondary listings inside our databases.